In its response [15], the ACOG concluded that available studies show no clear evidence that proves a direct relationship between the prudent use of APAP during any trimester and fetal developmental issues. The ACOG further concluded that physicians should not change clinical practice until definitive prospective research is done. Considering the ACOG response, it is important to note that evidence of APAP inducing neurodevelopmental problems during the prenatal period is concerning but limited [2,16,17]
At roughly $550/month for the lower doses, it undercuts what many patients have been paying for third-party compounders once shipping and consultation fees are factored in
Furthermore, heavy metals are also agents that cause free radicals and inflammation to the blood vessels
Storing Your Medication Proper storage is critical to maintaining the medications stability and effectiveness
Probl Cardiol
This page is not medical advice, not a product recommendation, and does not tell anyone to use, buy, or self-administer any compound